Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02907801 · ClinicalTrials.gov registry record · NA
Perception-Action Approach Intervention for Infants With Congenital Muscular Torticollis
A NA study, sponsored by Rosalind Franklin University of Medicine and Science.
- Terminated
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT02907801 is a NA study that was terminated before completion, run by Rosalind Franklin University of Medicine and Science. The registered enrollment target is 5 participants.
The verdict
NCT02907801, a NA study, was terminated before completion, sponsored by Rosalind Franklin University of Medicine and Science.
- TERMINATED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
Infants with congenital muscular torticollis (CMT) display postural and functional asymmetry that interferes with their development. The use of the Perception-Action Approach (P-AA) intervention in infants with CMT is supported by a single case report and needs to be researched further to determine its efficacy. This study will investigate the immediate effects of the P-AA intervention on habitual head deviation from midline, active head rotation range of motion, and functional use of both sides of the body in infants with CMT. The participants will be 3 infants with CMT, aged birth to 9 months. A randomized, nonconcurrent A-B multiple baseline design across subjects will be used. The intervention phase will include 5 daily PT sessions, with outcome data collected at the end of each session. It is hypothesized that improvements on all outcome measures will be documented upon the initiation of the P-A Approach intervention, with the most substantial change expected in habitual head deviation from midline measured by still photography.
Interventions
- BEHAVIORAL Perception-Action Approach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2017-01-10 |
| Est. Completion | 2018-03-26 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02907801
The ClinicalTrials.gov registry entry for NCT02907801 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rosalind Franklin University of Medicine and Science, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Perception-Action Approach is the first listed.
NCT02907801 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02907801 about?
NCT02907801 is a clinical study titled "Perception-Action Approach Intervention for Infants With Congenital Muscular Torticollis". Infants with congenital muscular torticollis (CMT) display postural and functional asymmetry that interferes with their development. The use of the Perception-Action Approach (P-AA) intervention in infants with CMT is supported by a single case report and needs to be researched further to determine ...
What is the current status of trial NCT02907801?
This trial is currently terminated. It is a NA study. The enrollment target is 5 participants. The study started on 2017-01-10. Estimated completion is 2018-03-26.
What interventions are being tested in trial NCT02907801?
The interventions under investigation include: Perception-Action Approach (BEHAVIORAL).
Who is sponsoring clinical trial NCT02907801?
This trial is sponsored by Rosalind Franklin University of Medicine and Science, which has 8 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.